Atuka

Atuka offers comprehensive preclinical services in gene therapy, utilizing advanced rodent and non-human primate models to support therapeutic development. Our expertise includes gene therapy delivery technologies, biodistribution studies, imaging, and pharmacokinetics, helping to evaluate efficacy and safety. We provide tailored approaches for AAV-based gene therapies and ASOs, ensuring high translatability to clinical phases. Atuka also specialises in preclinical models of neurodegenerative diseases, in rodent and non-human primate, particularly for Parkinson’s disease.